Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04610515 · ClinicalTrials.gov registry record
Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)
A clinical trial, sponsored by Rush University Medical Center.
- Completed
- Registry status
- 6,000
- Enrollment target
NCT04610515: Completed study, sponsored by Rush University Medical Center.
NCT04610515 is a clinical trial that has completed, run by Rush University Medical Center. The registered enrollment target is 6,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04610515 has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- 6,000 participants
- Enrollment target
Study Summary
The Innovative Support for Patients with SARS COV-2 Infections Registry (INSPIRE) study is a CDC-funded COVID-19 project to understand the long-term health outcomes in recently tested adults, both negative and positive, who have suspected COVID symptoms at the time of their test. Participants will complete short online surveys every 3 months for 18 months, share information about their health using a secure web-based platform, and are compensated for their time.
Primary Outcome
Clinical phenotypes of sequelae will be determined at the time of analysis based on published literature
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,000 participants |
| Start Date | 2020-12-15 |
| Est. Completion | 2025-10-31 |
What the finished NCT04610515 record still lists
NCT04610515 is an observational study that tracks outcomes without assigning an intervention. Its 6,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04610515 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04610515 about?
NCT04610515 is a clinical study titled "Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)". The Innovative Support for Patients with SARS COV-2 Infections Registry (INSPIRE) study is a CDC-funded COVID-19 project to understand the long-term health outcomes in recently tested adults, both negative and positive, who have suspected COVID symptoms at the time of their test. Participants will c...
What is the current status of trial NCT04610515?
This trial is currently completed. The enrollment target is 6,000 participants. The study started on 2020-12-15. Estimated completion is 2025-10-31.
Who is sponsoring clinical trial NCT04610515?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
- NCT03127631 · 6,000 participants · NA
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
- NCT03539705 · 6,000 participants
Food Allergy Registry at a Single Site
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI